Zheng Zhou

Discovery of novel druggable binding pockets on SARS-CoV-2 PLpro via fragment screening and insights for structure-based inhibitor design

A fragment-based drug discovery strategy combined with crystallographic screening and structural similarities among the fragments provide a robust structural framework for the rational design of PLpro inhibitors and support the development of novel antiviral therapeutics.